IRIS

Sfoglia per Autore  

Opzioni
Mostrati risultati da 41 a 60 di 160
Titolo Data di pubblicazione Autore(i) File
1H NMR-based metabolic profiling of urine from children with nephrouropathies 1-gen-2010 Atzori, L; Antonucci, Roberto; Barberini, L; Locci, E; Cesare Marincola, F; Scano, P; Cortesi, P; Agostiniani, R; Weljie, A; Lai, A; Fanos, V.
Antenatal non-steroidal antiinflammatory drugs and the neonatal kidney 1-gen-2011 Antonucci, Roberto; Zaffanello, M; Pilloni, Md; Fanos, V.
Metabolomics & Patent Ductus Arteriosus diagnosis: is 1H-NMR (Nuclear Magnetic Resonance) Spectroscopy of urine at birth predictive as ultrasound? 1-gen-2011 Atzori, L; Barberini, L; Lussu, M; Murgia, F; Noto, A; Mercuro, G; Bassareo, P; Puddu, M; Antonucci, Roberto; Neroni, P; Tumbarello, R; Fanos, V.
Acute nephrotoxicity of NSAID from the foetus to the adult 1-gen-2011 Musu, M; Finco, G; Antonucci, Roberto; Polati, E; Sanna, D; Evangelista, M; Ribuffo, D; Schweiger, V; Fanos, V.
Sicurezza dei pazienti e gestione del rischio clinico 1-gen-2011 Antonucci, Roberto
Renal safety of Non Steroidal Anti Inflammatory Drugs (NSAIDs) in the pharmacologic treatment of patent ductus arteriosus 1-gen-2011 Fanos, V; Marcialis, Ma; Bassareo, Pp; Antonucci, Roberto; Zaffanello, M; Dessì, A; Iacovidou, N.
Metabolomics in neonatology and pediatrics 1-gen-2011 Fanos, V; Barberini, L; Antonucci, Roberto; Atzori, L.
1H NMR-based metabolomic analysis of urine from preterm and term neonates 1-gen-2011 Atzori, L; Antonucci, Roberto; Barberini, L; Locci, E; Marincola, Fc; Scano, P; Cortesi, P; Agostiniani, R; Defraia, R; Weljie, A; Gazzolo, D; Lai, A; Fanos, V.
Renal safety of antifungals and non-steroidal anti-inflammatory drugs in the newborn 1-gen-2011 Fanos, V; Mussap, M; Cuzzolin, L; Antonucci, Roberto; Tomé, T; Guimarães, H.
Isoprostane levels in urine of preterm newborns treated with ibuprofen for patent ductus arteriosus closure 1-gen-2011 Longini, M; Perrone, S; Vezzosi, P; Proietti, F; Marzocchi, B; Buonocore, G; Fanos, V; Antonucci, Roberto; Brunoldi, E.
Current pharmacotherapy in the newborn. 1-gen-2012 Antonucci, Roberto; Porcella, A.
Pharma-metabolomics in neonatology: is it a dream or a fact? 1-gen-2012 Fanos, V; Barberini, L; Antonucci, Roberto; Atzori, L.
Clinical application of metabolomics in neonatology 1-gen-2012 Fanos, V; Antonucci, Roberto; Barberini, L; Noto, A; Atzori, L.
Use of Non-steroidal Anti-inflammatory Drugs in Pregnancy: Impact on the Fetus and Newborn 1-gen-2012 Antonucci, Roberto; Zaffanello, M; Puxeddu, E; Porcella, A; Cuzzolin, L; Pilloni, Md; Fanos, V.
Nenatal drug induced nephrotoxicity : old and next generation biomarkers for early detection and management of neonatal drug-induced nephrotoxicity, with special emphasis on uNGAL and on metabolomics 1-gen-2012 Fanos, V; Antonucci, Roberto; Zaffanello, M; Mussap, M.
Liposomal amphotericin B does not induce nephrotoxicity or renal function impairment in premature neonates 1-gen-2012 Manzoni, P; Galletto, P; Rizzollo, S; Franco, C; Gallo, E; Antonucci, Roberto; Fanos, V; Farina, D.
Metabolomics explained to perinatologists and pediatricians 1-gen-2012 Atzori, L; Barberini, L; Santoru, Ml; Antonucci, Roberto; Fanos, V.
Urinary metabolomics in newborns and infants 1-gen-2012 Fanos, V; Antonucci, Roberto; Barberini, L; Atzori, L.
Timing e modalità del parto. Il punto di vista del Neonatologo 1-gen-2012 Antonucci, Roberto; Porcella, A; Pilloni, Md
Pharmaceutical research and metabolomics in the newborn 1-gen-2012 Antonucci, Roberto; Pilloni, Md; Atzori, L; Fanos, V.
Mostrati risultati da 41 a 60 di 160
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile